Al-Uffi v. Secretary of Health and Human Services

CourtUnited States Court of Federal Claims
DecidedOctober 21, 2015
Docket13-956
StatusPublished

This text of Al-Uffi v. Secretary of Health and Human Services (Al-Uffi v. Secretary of Health and Human Services) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Al-Uffi v. Secretary of Health and Human Services, (uscfc 2015).

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 13-956V (To be Published)

************************* LEILAH AL-UFFI, on behalf of her minor * child, R.B., * * Special Master Corcoran Petitioner, * * Dated: September 30, 2015 v. * * Attorney’s Fees and Costs; * Reasonable Basis; Interim Fees; SECRETARY OF HEALTH AND * Expert Costs HUMAN SERVICES, * * Respondent. * * *************************

Andrew Donald Downing, Van Cott & Talamante, PLC, Phoenix, AZ, for Petitioner.

Debra A. Begley, U.S. Dep’t of Justice, Washington, DC, for Respondent.

INTERIM ATTORNEY’S FEES AND COSTS DECISION1

On December 5, 2013, Leilah Al-Uffi filed a petition on behalf of her minor child, R.B., seeking compensation under the National Vaccine Injury Compensation Program (the “Vaccine Program”).2 Having filed numerous medical records, along with three reports from two experts, Petitioner has now requested an interim award of attorney’s fees and costs in the amount of $48,898.50. Respondent objects that an interim fees award is not warranted at this juncture because Petitioner has not made the requisite special showing. In the alternative, should I determine that

1 Because this decision contains a reasoned explanation for my actions in this case, I will post it on the United States Court of Federal Claims website, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, § 205, 116 Stat. 2899, 2913 (Dec. 17, 2002) (current version at 44 U.S.C. § 3501 (2014)). As provided by 42 U.S.C. § 300aa- 12(d)(4)(B), however, the parties may object to the decision’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole decision will be available to the public. Id. 2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3758, codified as amended at 42 U.S.C. §§ 300aa-10 through 34 (2012) [hereinafter “Vaccine Act” or “the Act”]. Individual section references hereafter will be to § 300aa of the Act (but will omit that statutory prefix). an interim fees award is appropriate, Respondent argues that 1) the hourly rate requested for Petitioner’s primary counsel, Andrew Downing, is not reasonable; 2) some of the time billed was duplicative; and 3) the retained experts in this case have charged an excessive hourly rate. As discussed below, I hereby GRANT IN PART Petitioner’s Motion, awarding at this time interim fees and costs of $38,073.20, while deferring action on any expert-related costs.

Factual History

At the age of twelve, R.B. received her third dose of Gardasil,3 the human papilloma virus vaccine, on December 8, 2010, at the University of Oklahoma, Tulsa Pediatric Clinic. Pet. at 1, filed Dec. 5, 2013 (ECF No.1) [hereinafter “Pet.”]; Pet’r’s Ex. 6 at 37. Prior to that date, R.B. appears to have been developing normally, and there are no noted neurological concerns about her contained in the filed medical records. Pet. at 1. Approximately two days after receipt of the final Gardasil dose, R.B. became confused, and by the third day began speaking in a slurred and unfamiliar manner. Id. R.B. thereafter become so agitated and disoriented that Ms. Al-Uffi (R.B.’s mother) took her to a local hospital’s emergency room on December 13, 2010. Pet’r’s Ex. 1 at 1- 2; Pet’r’s Ex. 6 at 38. At this time, petechiae were observed on the soles of R.B.’s feet in a bilateral pattern and she engaged in spells of lip-smacking, swallowing, and chewing. Her initial treaters diagnosed her with acute encephalopathy. Pet’r’s Ex. 4 at 22.

A few weeks later, R.B. was admitted to Cook Children’s Medical Center on January 5, 2011, after she exhibited further abnormal movements and agitated, aggressive behavior. Pet’r’s Ex. 2 at 4-5; Pet’r’s Ex. 6 at 38, 42. Testing revealed right-sided temporal lobe abnormalities in R.B.’s brain, and she was incontinent, and at times catatonic. Pet. at 2. R.B. was ultimately diagnosed with an anti-NMDA receptor encephalitis (an autoimmune reaction against NMDA- receptor subunits) after she tested positive for NMDA-receptor antibodies. Pet’r’s Ex. 2 at 12. She continues to suffer from the residual effects of the encephalitis. Pet. at 2. Petitioner alleges that R.B.’s receipt of the third dose of the Gardasil vaccine caused her autoimmune encephalitis. Id. at 1.

Procedural History

Ms. Al-Uffi filed this action on December 5, 2013. She thereafter began the process of gathering and filing relevant medical records, proposing a deadline of March 31, 2014, for filing a statement of completion of the record, to which Respondent agreed (although that deadline was not formally ordered). Status Report, filed Feb. 28, 2014 (ECF No. 11).

Petitioner subsequently failed to file a Statement of Completion by the date she had proposed, and also failed to file a status report regarding her progress in collecting documents. 3 Gardasil is the trademark name for a preparation of human papillomavirus quadrivalent recombinant vaccine. Dorland’s Illustrated Medical Dictionary 761 (32d ed. 2012).

2 Eventually, enough time passed without action on Petitioner’s behalf that I issued an Order to Show Cause on June 13, 2014 (ECF No. 15), demanding that Ms. Al-Uffi act or risk dismissal of the petition. In a response filed that same day (ECF No. 16), Petitioner explained that she had faced problems in collecting the relevant records, but pledged to complete the task. Ms. Al-Uffi eventually filed her Statement of Completion on July 30, 2014. ECF No. 19.

Since the completion of records filing, the case has proceeded swiftly. I initially set a deadline of September 29, 2014, for Respondent’s Rule 4 Report. June 13, 2014 Order. Before that deadline had been reached, however, Petitioner went ahead and filed an expert report and supporting literature from Dr. David Axelrod on August 27, 2014. ECF No. 21. A status conference was then held on September 24, 2014, during which Respondent requested a further extension of time for the filing of her Rule 4 Report, in order to incorporate in her response the contents of an additional expert report from one of R.B.’s treating physicians, Dr. David Siegler, that Petitioner indicated she would be filing (and did so thereafter on Oct. 10, 2014 (ECF No. 23)). On December 12, 2014, Respondent filed her Rule 4 Report along with a responsive expert report from Dr. Mark Gorman. ECF Nos. 24, 25, 26. The Report identified missing medical records, which Petitioner filed on January 8, 2015. ECF No. 28.

Petitioner subsequently filed a supplemental expert report from Dr. David Axelrod on February 3, 2015. ECF Nos. 32, 33. A Joint Status Report filed March 12, 2015, indicated that the parties believed there were outstanding records still not filed. ECF No. 34. Petitioner therefore filed a motion requesting authorization for service of a subpoena on the entities in possession of such records (ECF No. 35), and I granted the request. ECF No. 36. Those subpoenaed materials have since been filed. During a status conference on August 5, 2015, I set a deadline for Respondent’s supplemental expert report of September 18, 2015, with which Respondent complied.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hensley v. Eckerhart
461 U.S. 424 (Supreme Court, 1983)
Blum v. Stenson
465 U.S. 886 (Supreme Court, 1984)
Avera v. Secretary of Health and Human Services
515 F.3d 1343 (Federal Circuit, 2008)
Fox v. Vice
131 S. Ct. 2205 (Supreme Court, 2011)
Shaw v. Secretary of Health and Human Services
609 F.3d 1372 (Federal Circuit, 2010)
Guerrero v. Secretary of Health and Human Services
120 Fed. Cl. 474 (Federal Claims, 2015)
Edgar ex rel. Edgar v. Secretary of Department of Health
32 Fed. Cl. 506 (Federal Claims, 1994)
Grice v. Secretary of Health & Human Services
36 Fed. Cl. 114 (Federal Claims, 1996)
Guy v. Secretary of Health & Human Services
38 Fed. Cl. 403 (Federal Claims, 1997)
Hanlon v. Secretary of Health & Human Services
40 Fed. Cl. 625 (Federal Claims, 1998)
Preseault V. United States
52 Fed. Cl. 667 (Federal Claims, 2002)
Guillory v. United States
59 Fed. Cl. 121 (Federal Claims, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
Al-Uffi v. Secretary of Health and Human Services, Counsel Stack Legal Research, https://law.counselstack.com/opinion/al-uffi-v-secretary-of-health-and-human-services-uscfc-2015.